Gregory P Licholai - VP, Amicus Therapeutics Inc
As of February 5, 2009
What is Gregory P Licholai's Net Worth?
The current estimated net worth of Amicus Therapeutics Inc's VP, Gregory P Licholai, is estimated to be about $641.54K . Gregory P Licholai owns about 152 units of Amicus Therapeutics Inc common stock. In the last year at Amicus Therapeutics Inc, Gregory P Licholai has sold an estimated value of $415.3K worth.
What is Gregory P Licholai's Past Insider Trading?
Gregory P Licholai's largest purchase order was 15,000 units , worth over $9.56K on July 17, 2008. Gregory P Licholai's largest sale order was 15,000 units , worth over $195K on July 17, 2008. In total, Gregory P Licholai has made about 6 transactions over a year of their time at Amicus Therapeutics Inc. Gregory P Licholai usually trades in February, with the busiest year in 2008. The most recent transaction was a sale order of 1,401 units , worth over $21.16K on August 20, 2008.
Gregory P Licholai
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Gregory P Licholai's' Mailing Address?
- Mailing address is C/o Amicus Therapeutics, Inc. 6 Cedar Brook Drive Cranbury NJ 08512 NJ
Amicus Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Change in Pension Value
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| John F. Crowley | 2020 | $719,514 | $514,800 | $5,479,971 | $2,492,491 | $1,282,843 | $825,505 | $11,315,124 |
| John F. Crowley | 2019 | $656,770 | $476,815 | $5,327,948 | $2,334,850 | $234,775 | $821,505 | $9,852,663 |
| John F. Crowley | 2018 | $637,640 | $445,710 | $3,861,699 | $1,654,347 | - | $820,567 | $7,419,963 |
| Daphne Quimi | 2020 | $45 | $228,712 | $1,534,382 | $697,894 | - | $34,639 | $2,947, |
| Daphne Quimi | 2019 | $400,000 | $212,960 | $1,311,492 | $538,808 | - | $17,487 | $2,480,747 |
| Daphne Quimi | 2018 | - | - | - | - | - | - | - |
| Bradley L. Campbell | 2020 | $515, | $368,872 | $2,557,304 | $1,163,159 | - | $33,694 | $4, |
| Bradley L. Campbell | 2019 | $500,877 | $378,788 | $2,254,114 | $987,822 | - | $19,538 | $4,141,139 |
| Bradley L. Campbell | 2018 | $468,109 | $327,209 | $1,411,802 | $604,817 | - | $16,710 | $2,828,646 |
| Hung Do | 2020 | $42 | $187,908 | $1,461,322 | $664,660 | - | $31,248 | $2,772,106 |
| Hung Do | 2019 | $414,625 | $200,678 | $1,393,462 | $574,732 | - | $22,129 | $2,605,626 |
| Hung Do | 2018 | - | - | - | - | - | - | - |
| Ellen S. Rosenberg | 2020 | $452, | $199,051 | $1,461,322 | $664,660 | $87,751 | $20,748 | $2,885,820 |
| Ellen S. Rosenberg | 2019 | $439,213 | $233,837 | $1,393,462 | $610,648 | - | $13,538 | $2,690,698 |
| Ellen S. Rosenberg | 2018 | $426,420 | $208,647 | $996,591 | $426,933 | - | $18,270 | $2,076,862 |
| Jay Barth | 2020 | $366,269 | - | $1,315,184 | $598,197 | - | $641,306 | $2,920,956 |
| Jay Barth | 2019 | $471,621 | $228,265 | $1,229,522 | $538,808 | - | $15,998 | $2,484,214 |
| Jay Barth | 2018 | $457,885 | $192,037 | $996,591 | $426,933 | - | $18,790 | $2,092,236 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1178879/000114036121014545/nc10021408x1_def14a.htm
What are Amicus Therapeutics Inc's Past Insider Trades?
Amicus Therapeutics Inc's most recent insider trade came on June 22, 2022 by Bradley Campbell who sold 16,410 units worth $164.1K . In the last 15 years, insiders at Amicus Therapeutics Inc have sold an estimated value of $174.05M and bought an estimated value of $192.04M worth of shares. Insider trading is most common in June, with the busiest year in 2008. The most active traders at the company are John Crowley, Chairman & CEO, Bradley Campbell, Chief Operating Officer, and James N Topper, Director .
AMICUS THERAPEUTICS, INC. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||